This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Headache  • Drug Therapy  • Drug Therapy, Other  • Facial Plastic Surgery  • Cosmetic Surgery/ Procedures  • Alert me on articles by topic  Social Bookmarking   What's this?

Form Over Substance

Ann Pakalnis, MD; James Couch, MD

Arch Neurol. 2008;65(1):149-151.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Headache is one of the most common neurologic problems encountered in clinical practice. Migraine affects about 15% of the adult population in the United States.¹ Frequent migraine attacks can be disabling and cause significant limitations in work, family, and social responsibilities, especially because many individuals with migraine are in their prime years of life for working and family rearing. Even more disruptive are the chronic headache disorders (15 or more headache days per month, according to criteria from the International Classification of Headache Disorders II).² These headaches probably affect about 4% of the population worldwide; they are more frequent and sometimes more disabling than other chronic neurologic disorders such as epilepsy.^3-4 In addition, overuse of over-the-counter and prescription medications by individuals with chronic headache can lead to significant adverse effects as well as other complications.

The frequency and severity of recurrent headaches justify a . . . [Full Text of this Article]

REVIEW OF MIGRAINE STUDIES


REVIEW OF CHRONIC DAILY HEADACHE STUDIES

SUMMARY

AUTHOR INFORMATION
Author Affiliations: Departments of Pediatrics and Neurology, Ohio State University, Columbus (Dr Pakalnis), and Department of Neurology, University of Oklahoma, Oklahoma City (Dr Couch).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Botulinum Toxin Type A for the Treatment of Headache: Why We Say Yes
Avi Ashkenazi and Stephen Silberstein
Arch Neurol. 2008;65(1):146-149.
EXTRACT | FULL TEXT  

Questioning Botulinum Toxin for Headache: Reality or Illusion
E. S. Roach
Arch Neurol. 2008;65(1):151-152.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Questioning Botulinum Toxin for Headache: Reality or Illusion
Roach
Arch Neurol 2008;65:151-152.
FULL TEXT